Protocol for the examination of specimens from patients with non-Hodgkin lymphoma/lymphoid neoplasms.

Authors Jerry W. Hussong, MD, DDS, FCAP* Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California Daniel A. Arber, MD Department of Pathology, Stanford University School of Medicine, Stanford, California Kyle T. Bradley MD, MS, FCAP Department of Pathology and Laboratory Medicine, Emory University Hospital, Atlanta, Georgia Michael S. Brown, MD, FCAP Department of Pathology, Yellowstone Pathology Institute Inc, Billings, Montana Chung-Che Chang, MD, PhD, FCAP Department of Pathology, The Methodist Hospital, Houston, Texas Monica E. de Baca, MD, FCAP Department of Pathology and Laboratory Medicine, Physicians Laboratory Ltd, Sioux Falls, South Dakota David W. Ellis, MBBS, FRCPA Department of Anatomical Pathology, Flinders Medical Centre, Bedford Park, South Australia Kathryn Foucar, MD, FCAP Department of Pathology, University of New Mexico, Albuquerque, New Mexico Eric D. Hsi, MD, FCAP Department of Clinical Pathology, Cleveland Clinic Foundation, Cleveland, Ohio Elaine S. Jaffe, MD Hematopathology Section, Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland Joseph Khoury, MD, FCAP Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas Michael Lill, MB, BS, FRACP, FRCPA Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California Stephen P. McClure, MD Department of Pathology and Laboratory Medicine, Presbyterian Pathology Group, Charlotte, North Carolina L. Jeffrey Medeiros, MD, FCAP Department of Hematopathology, MD Anderson Cancer Center, Houston, Texas Sherrie L. Perkins, MD, PhD, FCAP Department of Pathology, Hematopathology, University of Utah Health Sciences Center, Salt Lake City, Utah For the Members of the Cancer Committee, College of American Pathologists